Phibro Animal Health Corporation (PAHC)

Total asset turnover

Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
Revenue (ttm) US$ in thousands 1,296,215 1,190,682 1,106,080 1,046,762 1,017,630 999,515 981,965 976,668 977,889 978,140 972,086 960,152 942,296 907,296 879,406 852,843 833,372 798,972 797,982 805,845
Total assets US$ in thousands 1,360,900 1,317,260 1,285,510 966,289 982,184 979,035 972,708 964,523 971,397 965,432 961,833 948,378 931,699 916,181 848,958 836,044 841,325 805,017 803,651 789,554
Total asset turnover 0.95 0.90 0.86 1.08 1.04 1.02 1.01 1.01 1.01 1.01 1.01 1.01 1.01 0.99 1.04 1.02 0.99 0.99 0.99 1.02

June 30, 2025 calculation

Total asset turnover = Revenue (ttm) ÷ Total assets
= $1,296,215K ÷ $1,360,900K
= 0.95

The total asset turnover ratio of Phibro Animal Health Corporation has historically reflected a stable pattern, indicating consistent efficiency in utilizing its assets to generate sales. From September 30, 2020, through March 31, 2024, the ratio remained relatively steady within a narrow band approximately between 0.99 and 1.08, suggesting the company maintained a consistent level of asset efficiency over this period. Notably, there was a slight increase on September 30, 2024, reaching 1.08, which indicates a marginal improvement in the company's ability to generate sales per dollar of assets. However, this upward trend was not sustained, as the ratio declined sharply to 0.86 by December 31, 2024, signaling a decrease in asset efficiency. Subsequently, the ratio showed modest improvement in the following quarters, reaching around 0.90 to 0.95 by June 30, 2025. Overall, the pattern suggests that while Phibro Animal Health Corporation's asset utilization was stable for several years, recent fluctuations point to periods of reduced efficiency, which could be influenced by changes in operational performance, asset management, or external market factors.